Press
Surge raises $26M to take anti-cancer extended-release hydrogel into the clinic • Fierce Pharma
Media Coverage
|
18 October 2022
SURGE Therapeutics Raises $26M Series A Financing to Accelerate Development of Intraoperative Immunotherapy to Improve Survival Outcomes Post-Surgery
Press Releases
|
17 October 2022
Surge launches to enhance cure rates for cancer surgery • Chemical & Engineering News
Media Coverage
|
17 October 2022
Bob Langer, Cancer Research Institute Back Intraoperative Immunotherapy Pioneer • Biospace
Media Coverage
|
17 October 2022